|
Assessment of Potential Interactions Between Intravenous Methamphetamine and Oral Selegiline - 1 Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or treatment with a real dr.. We aren't doctors. Always consult your mD on Assessment of Potential Interactions Between Intravenous Methamphetamine and Oral Selegiline - 1 conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Assessment of Potential Interactions Between Intravenous Methamphetamine and Oral Selegiline - 1 Clinical research trials and Assessment of Potential Interactions Between Intravenous Methamphetamine and Oral Selegiline - 1 medical trials occur in many of places across the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectiveness of new does drugs. The role of the studies / undertakings is to figure out certain human healthcare questions. Clinical trials are a popular means for doctors, government agencies, and private sector corporations to locate treatments for all forms of circumstances, including Assessment of Potential Interactions Between Intravenous Methamphetamine and Oral Selegiline - 1. Assessment of Potential Interactions Between Intravenous Methamphetamine and Oral Selegiline - 1 Clinical Trials and other clinical trials permit volunteers to get medical treatment options before they are available to the masses. Most times the human subjects acquire treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a Assessment of Potential Interactions Between Intravenous Methamphetamine and Oral Selegiline - 1 clinical trial. Participants oftentimes recieve the finest healthcare available for their Assessment of Potential Interactions Between Intravenous Methamphetamine and Oral Selegiline - 1 condition. Dangers are a reality, nonetheless, and might include extra or frequent physician calls, health hazards (potentially life-endangering), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > Assessment of Potential Interactions Between Intravenous Methamphetamine and Oral Selegiline - 1  Assessment of Potential Interactions Between Intravenous Methamphetamine and Oral Selegiline - 1
Assessment of Potential Interactions Between Intravenous Methamphetamine and Oral Selegiline - 1
For Condition: Substance-Related Disorders,Infusions, Intravenous,Substance Abuse, Intravenous
Status: No longer recruiting
Sponsor(s): National Institute on Drug Abuse (NIDA) ,
Synopsis: An assessment of potential interactions between intravenous methamphetamine and oral selegiline.
Details: To determine the safety of the selegiline concurrent with d-methamphetamine challenges of 15mg & 30mg i.v. with the focus being on cardiovascular responses (HR,BP) to the i.v. methamphetamine challenges. This is a randomized, single-blind, placebo-controlled, two-arm study design to evaluate the safety of selegiline treatment, compared to placebo treatment, concurrent with i.v. methamphetamine challenges.
Eligibility:
Study Type: Interventional, Treatment, Randomized, Single Blind, Placebo Control
Minimum Age/Maximum Age: 18 Years/45 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: Volunteers who meet DSM-4 criteria for methamphetamine abuse or dependence; non-treatment seeking individuals; between 18-45 yrs of age; be able to verbalize understanding of consent form; provide written informed consent Exclusion Criteria: Additional criteria available during screening at the site
Total Enrollment: 16
Location and Contact Information:
Overall Study Official:
ThomasNewton, Principal Investigator, University of California, Los Angeles
UCLA Integrated Substance Abuse Program
Los Angeles, California, 90024
United States
Additional Information:
Study ID Numbers: NIDA-CTO-0004-1;
Study Start Date: September 2001
Record last reviewed: November 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00033072
Other Infusions, Intravenous Studies:
1. Effects of Subanesthetic Concentrations of Isoflurane/Nitrous Oxide - 3
2. Methylphenidate Raclopride PET test - 11
3. Pharmacotherapy for Schizophrenic Drug Users - 6
4. Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4
5. Effects of Behavioral Contingencies on Effects of Nitrous Oxide - 12
Related Studies:
Other Infusions, Intravenous Clinical Trials
Other California Clinical Trials
Other Los Angeles Clinical Trials
Assessment of Potential Interactions Between Intravenous Methamphetamine and Oral Selegiline - 1
|
|
|
|
|
|
|
|
